Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: brad greene who wrote (9308)	7/15/1998 11:16:00 AM
From: David	Read Replies (1) \| Respond to of 26039

Brad, that analysis makes a good deal of sense to me, too, but here's how I'd like to see it play out: (1) At the right time, sell ANADAC. The GSA schedule live scan stuff gets held back from the sale. This could happen even in the next year. (2) IDX quickly uses the proceeds to buy out another company or reinvest in its own bio-ID. (3) After the bio-ID takes off as the fastest-growing part of the company, sell the live scan business (a) if the price is right and (b) if you have a better use for the money. I don't see this happening for two or three years, though. The effect of this approach is that your need to borrow or issue more stock, i.e., dilute earnings, is greatly decreased. You grow the business from the inside.